These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 23359527)
1. Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity. Kang CH; Tsai CM; Wu TH; Wu HY; Chung MY; Chen CC; Huang YC; Liu SF; Liao DL; Niu CK; Lee CH; Yu HR Pediatr Pulmonol; 2014 Apr; 49(4):381-8. PubMed ID: 23359527 [TBL] [Abstract][Full Text] [Related]
2. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293 [TBL] [Abstract][Full Text] [Related]
3. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Nakwan N; Wannaro J; Thongmak T; Pornladnum P; Saksawad R; Nakwan N; Chokephaibulkit K Pediatr Pulmonol; 2011 Jan; 46(1):60-6. PubMed ID: 20812247 [TBL] [Abstract][Full Text] [Related]
4. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia. Arnold HM; Sawyer AM; Kollef MH Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038 [TBL] [Abstract][Full Text] [Related]
5. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ; Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092 [TBL] [Abstract][Full Text] [Related]
7. Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review. Celik IH; Oguz SS; Demirel G; Erdeve O; Dilmen U Eur J Pediatr; 2012 Feb; 171(2):311-6. PubMed ID: 21809011 [TBL] [Abstract][Full Text] [Related]
8. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? Kalin G; Alp E; Coskun R; Demiraslan H; Gündogan K; Doganay M J Infect Chemother; 2012 Dec; 18(6):872-7. PubMed ID: 22644081 [TBL] [Abstract][Full Text] [Related]
9. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994 [TBL] [Abstract][Full Text] [Related]
10. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii? Demirdal T; Sari US; Nemli SA Ann Clin Microbiol Antimicrob; 2016 Feb; 15():11. PubMed ID: 26911714 [TBL] [Abstract][Full Text] [Related]
11. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study. Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727 [TBL] [Abstract][Full Text] [Related]
12. Impact of colistin-initiation delay on mortality of ventilator-associated pneumonia caused by A. baumannii. Samrah S; Bashtawi Y; Hayajneh W; Almomani B; Momany S; Khader Y J Infect Dev Ctries; 2016 Oct; 10(10):1129-1134. PubMed ID: 27801377 [TBL] [Abstract][Full Text] [Related]
14. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii]. Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381 [TBL] [Abstract][Full Text] [Related]
15. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis. Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836 [TBL] [Abstract][Full Text] [Related]
16. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand. Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431 [TBL] [Abstract][Full Text] [Related]
18. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Falagas ME; Sideri G; Korbila IP; Vouloumanou EK; Papadatos JH; Kafetzis DA Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485 [TBL] [Abstract][Full Text] [Related]